Explore our clinically tested, dermatology-grade recovery creams, serums, and targeted treatment systems engineered for damaged skin barriers.
Guangdong Kofi Beauty Co. Ltd. — Bringing pharmaceutical-grade precision and advanced biotechnology to professional aesthetic skincare manufacturing.
Founded in 2009, Guangdong Kofi Beauty Co. Ltd. stands as a premier research-oriented manufacturing power in the global cosmetics industry. Our focus centers heavily on dermatological health, specifically the rehabilitation of damaged epidermal barriers. As an integrated R&D and intelligent manufacturing base for dermatology and aesthetic skincare products, Kofi Beauty continuously explores new formulations, advanced functions, and effective skincare technologies, supported by patented innovations and customized product development.
Today, over 10,000 hospitals, dermatology clinics, and professional skincare institutions across more than 50 countries trust and use products associated with Kofi Beauty’s manufacturing expertise. This global recognition reflects our commitment to scientific advancement, product reliability, and deep understanding of evolving skincare trends. By combining clinical dermatology research with advanced cosmetic technology, we aim to bridge the gap between medical skincare and everyday beauty care.
We place strong emphasis on these three pillars, ensuring that every product is developed under strict quality control standards and delivers visible, reliable results. Through extensive academic collaborations and clinical studies, our formulations are optimized to target the biological pathways of barrier regeneration, reducing trans-epidermal water loss (TEWL) and down-regulating inflammatory cytokines.
Guangdong Kofi Beauty Co. Ltd. has built a strong international distribution network, working with exclusive partners in more than 15 countries worldwide. At the same time, the company continues to welcome new opportunities for experienced and forward-thinking skincare distributors and partners who share a passion for the global beauty industry. Driven by continuous innovation, we integrate scientific research, academic collaboration, and advanced manufacturing capabilities with strong market insight and customer-oriented service.
A glimpse into our state-of-the-art facility where cleanroom standards, clinical guidelines, and high-precision instruments ensure absolute product integrity.
To deliver products that satisfy medical-grade recovery specifications, our manufacturing facility operates under Class 100,000 (ISO 8) cleanroom standards. From the input of raw bio-actives to the final sealing of sterile containers, every phase is rigorously logged, analyzed, and controlled. Below are the key phases of our operations:
Understanding the intercellular lipid matrix and active ingredient synergy for optimal stratum corneum restoration.
The human skin barrier—specifically the stratum corneum—functions as a brick-and-mortar structure where corneocytes act as the bricks and intercellular lipids act as the mortar. This lipid matrix consists primarily of Ceramides, Cholesterol, and Free Fatty Acids in an approximate 3:1:1 molar ratio. When this delicate ratio is disrupted by aesthetic procedures (e.g., ablative laser resurfacing, chemical peels), environmental stressors, or systemic dermatoses, the skin becomes vulnerable to pathogens, allergens, and excessive trans-epidermal water loss (TEWL).
To address this clinical challenge, our R&D department focuses on bio-engineered molecules that mimic and accelerate the skin's natural healing cascade:
Clinical Insight: The efficacy of barrier recovery is not merely determined by the concentration of raw ingredients, but by the physical organization of the emulsion. Our advanced *Emulsifying Pots* generate sub-micron lipid droplets (100–300 nm) that easily penetrate the intercellular spaces of damaged skin, delivering bio-actives directly to target layers without causing occlusion or mechanical irritation.
How our global OEM/ODM solutions adapt to regional skin concerns, clinical requirements, and environmental challenges.
Specially tailored for clinical clinics in North America and Western Europe following fractional lasers, microneedling, or deep chemical peels. Formulations require sterile or ultra-pure packaging with no fragrances, emulsifiers, or preservatives that could trigger contact dermatitis. The focus is on recombinant collagen and PDRN to rapidly reduce recovery downtime.
Designed for Northern European, East Asian, and Canadian markets experiencing harsh, dry winters. These formulations utilize highly occlusive yet non-comedogenic lipid blends rich in Ceramides, squalane, and multi-weight hyaluronic acid to protect the skin from dry indoor heating and freezing outdoor winds.
Engineered for Southeast Asian and South American markets with high humidity. Consumers require lightweight, fast-absorbing textures (gel-creams, ampoules) that do not feel heavy or greasy, but still deliver therapeutic dosages of barrier-restoring lipids and anti-redness agents (Centella Asiatica, Madecassoside).
Targeted at metropolitan regions globally, where particulate matter (PM2.5) and heavy metals damage the epidermal barrier. Formulations integrate antioxidants, biosaccharide gum-4 film-formers, and niacinamide to prevent particulate adhesion, down-regulate oxidative stress, and repair the barrier daily.
Why sourcing from Guangdong Kofi Beauty Co. Ltd. offers unbeatable scale, speed, and safety advantages.
The global cosmetics industry operates in a dynamic landscape where speed-to-market and pricing stability dictate brand survival. Guangdong, China serves as the epicentre of global cosmetics manufacturing, housing an unparalleled cluster of raw material suppliers, packaging innovators, and logistics infrastructure. Kofi Beauty leverages these local advantages to pass significant benefits to our global partners:
Through close partnerships with leading biological fermentation labs in China, we secure medical-grade recombinant proteins and active ingredients at highly stable pricing, immune to the supply chain shocks common in other regions.
By integrating automated Three-Dimensional Packaging, Heat Shrinkable Film Machines, and high-speed Inkjet Printers, we eliminate human errors, minimize scrap rates, and compress assembly timelines by up to 40% compared to traditional manufacturers.
Our state-of-the-art laboratory and dedicated R&D team can refine and produce sample modifications within 3 to 5 business days, drastically lowering product development lead times and accelerating your time-to-market.
The evolutionary path of skin barrier recovery from topical lipid replacement to gene-level cellular regeneration.
Perfecting the structural mimicking of natural epidermal lipids. Utilizing recombinant Type III collagen to rebuild the dermal scaffolding, combined with ceramides and plant-based squalane to decrease TEWL and soothe acute erythema.
Harnessing plant and milk-derived exosomes to carry mRNA and peptide instructions directly to damaged skin cells, accelerating deep regeneration. Formulating prebiotic and postbiotic cultures to restore the skin microbiome's protective mantle.
Integrating genomic skin sequencing and AI diagnostic tools. Formulations will be dynamically custom-blended at our automated manufacturing lines in real-time, matching specific gene expressions and unique micro-barrier deficiencies of individual consumers.
Navigating global standards with comprehensive certification pipelines, safety portfolios, and localized regulatory support.
Entering international cosmetics markets demands rigorous scientific validation and regulatory documentation. Guangdong Kofi Beauty Co. Ltd. removes these hurdles by maintaining an absolute compliance posture across all global markets:
Essential answers for medical directors, product developers, and brand owners seeking to formulate high-efficacy barrier repair skincare.
Expand your product range with specialized post-operative gels, ampoule concentrates, atopic skin devices, and high-performance hydrocolloids.